EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A)

Kiesha Rice, Noora Lehtinen, Eetu Välimäki, Janne Suhonen, Pekka Taimen, Kimmo Kettunen, Sami Ventelä, Juha Kononen, Harri Sihto, Juha K Rantala

Journal of Molecular Medicine · 2026-12 · 104 (1)

DOI: 10.1007/s00109-026-02677-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Medicine, online erschienen am 28.04.2026. Verfasst von Kiesha Rice und 9 weiteren Autor:innen. Beteiligte Einrichtung: Misvik Biology Oy, Karjakatu 35 B, Turku, FI-20520, Finland. Hauptthemen laut MEDLINE: Cyclic Nucleotide Phosphodiesterases, Type 3, Neoplasms, Phosphodiesterase 3 Inhibitors. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclic Nucleotide Phosphodiesterases, Type 3NeoplasmsPhosphodiesterase 3 InhibitorsHumansAntineoplastic AgentsCell Line, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

AnagrelideEx vivo drug screeningPDE3APan-cancerRPPATarget evaluation

Substanzen

Cyclic Nucleotide Phosphodiesterases, Type 3PDE3A protein, humanPhosphodiesterase 3 InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Misvik Biology Oy, Karjakatu 35 B, Turku, FI-20520, Finland.
  • Docrates Cancer Center, Helsinki, 00180, Finland.
  • Institute of Biomedicine, University of Turku, Turku, Finland.
  • FICAN West Cancer Center, University of Turku and Turku University Hospital, Turku, Finland.
  • Department of Pathology, Laboratory Division, Turku University Hospital, Turku, Finland.
  • Turku Prostate Cancer Consortium, University of Turku, Turku, Finland.

Zitieren

APA

Rice, K., Lehtinen, N., Välimäki, E., Suhonen, J., Taimen, P., Kettunen, K., Ventelä, S., Kononen, J., Sihto, H., & Rantala, J. K. (2026). Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A). Journal of Molecular Medicine, 104(1). https://doi.org/10.1007/s00109-026-02677-7

Vancouver

Rice K, Lehtinen N, Välimäki E, Suhonen J, Taimen P, Kettunen K, et al. Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A). Journal of Molecular Medicine. 2026;104(1). doi:10.1007/s00109-026-02677-7

BibTeX
@article{Rice2026,
  author = {Rice, Kiesha and Lehtinen, Noora and Välimäki, Eetu and Suhonen, Janne and Taimen, Pekka and Kettunen, Kimmo and Ventelä, Sami and Kononen, Juha and Sihto, Harri and Rantala, Juha K},
  title = {Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A)},
  journal = {Journal of Molecular Medicine},
  year = {2026},
  volume = {104},
  number = {1},
  doi = {10.1007/s00109-026-02677-7}
}
Kostenlos starten →